McKesson leverages portfolio discipline in latest spin-off strategy

IRVING, Texas – McKesson is moving forward with a planned spin-off of its Medical-Surgical Solutions business, aiming to bring both organizations into “sharper focus.” The separation is designed to streamline operations, unlock growth opportunities, and enhance strategic execution across McKesson’s core platforms, company officials said at an Investor Day on Sept. 23. 

Medical-Surgical Solutions provides supply distribution, logistics and related services to health care providers across alternate care sites, including home medical equipment (HME) providers. The business accounted for 17% of McKesson’s adjusted operating profit in fiscal year 2025. 

“For Medical-Surgical, we believe that this separation will allow the business to emerge as a focused leader in alternate site medical supplies and distribution solutions with scale, breadth of capabilities and strong brands, and free to pursue an independent strategy with its own capital structure,” said McKesson, executive vice president and CFO. “We're confident that this separation will enable sharper focus, sharper strategic execution and operating focus, reduced complexity and enhanced execution overall, improved capital allocation discipline and accelerated performance and financial flexibility.” 

Strategic realignment and growth 

The spin-off will allow McKesson to concentrate on expanding its Oncology, Multispecialty, and Biopharma businesses, company officials say. In June, McKesson acquired a 70% controlling interest in CORE Ventures, founded by Florida Cancer Specialists & Research Institute, for $2.49 billion, further reinforcing its commitment to these growth areas. 

Progress toward independence 

Since announcing the separation in May, teams across both McKesson and Medical-Surgical have been working to establish Medical-Surgical’ s independence. Vitalone noted that while several key steps remain—such as transition service agreements, audited carve-out financial statements, and a new capital structure—the teams have made “tremendous progress.” 

“The separation presents manageable complexity,” he said. “The Medical-Surgical business largely operates separately today.” 

Tax-free separation and IPO path 

McKesson expects the separation to be tax-free for both the company and its shareholders, facilitated through an initial public offering (IPO). 

“Following a customary lock up period, McKesson intends to exit its remaining interest through a spin-off or split-off transaction or, potentially, a combination of both,” Vitalone said. 

Proven track record 

Vitalone emphasized McKesson’s experience with similar transactions. He referenced the company’s 2020 exit from Change Healthcare, which involved a split-off transaction allowing shareholders to exchange their McKesson shares for shares in PF2 SpinCo, a subsidiary holding McKesson’s stake in Change Healthcare. The spin-off was later merged into Change Healthcare Inc., converting SpinCo shares into Change Healthcare shares. 

“We've established a track record,” Vitalone said. “Our portfolio transformation has delivered consistently outstanding financial results, growth and returns to shareholders. We know how to execute with discipline, precision and clarity.” 

Timeline and outlook 

McKesson anticipates completing the separation of Medical-Surgical Solutions by the second half of calendar year 2027, subject to market conditions and regulatory approvals.